Skip to main content
SpringerLink
Log in

Stereoselectivity, a natural aspect of molecular biology: A blind spot in clinical pharmacology and pharmacokinetics

  • Letter to the Editor
  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Van’t Hoff I. H. (1874): Optisch actief vermogen en chemische constitutie van organische verbindingen. Ed. I. Greven, Utrecht, pp. 1–15.

    Google Scholar 

  2. Pasteur L. (1901): On the asymmetry of naturally occurring organic compounds, the foundations of stereochemistry. In: Richardson G. M. ed. Memoirs by Pasteur, Van’t Hoff, Le Bel and Wislicenus. New York, American Book Company.

    Google Scholar 

  3. Ariëns E. J., Wuis E. W. (1987): Bias in pharmacokinetics and clinical pharmacology. Clin. Pharmacol. Ther. 42, 361–363.

    PubMed  Google Scholar 

  4. Ariëns E. I., Wuis E. W. Veringa E. I. (1988): Stereoselectivity of bioactive xenobiotics: A pre-Pasteur attitude in medical chemistry, pharmacokinetics and clinical pharmacology. Biochem. Pharmacol. 37, 9–18.

    Article  PubMed  Google Scholar 

  5. Ariëns E. J. (1984): Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur. J. Clin. Pharmacol. 26, 663–668.

    Article  PubMed  Google Scholar 

  6. Series on chirality, (1986): Trends in Pharmacological Sciences, 7, 20–24, 60–65, 112–115, 155–158, 200–205, 227–230, 281–301.

    Google Scholar 

  7. Ariëns E. J. (1987): Implications of the neglect of stereochemistry in pharmacokinetics and clinical pharmacology. Drug Intell. Clin. Pharm. 21, 827–829.

    PubMed  Google Scholar 

  8. Ariëns E. J. (1988): Stereoselectivity ofbioactive agents, general aspects. In: Ariëns E.J., van Rensen J.J.S. eds. Pesticide stereoselectivity, biological and chemical problems. Welling, pp. 39–108.

  9. Drayer D.E. (1986): Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overview. Clin. Pharmacol. Ther. 40, 125.

    PubMed  CAS  Google Scholar 

  10. Wainer I. W., Drayer D. E. (1988): Drug stereochemistry. Analytical methods and pharmacology. New York, M. Dekker.

    Google Scholar 

  11. Ariëns E. J. (1988): Enzymes in stereospecific analysis. In: Chiral separations by HPLC: Applications to compounds of pharmacological interest. Krstulovic A. M. ed. Chichester, Wiley/Ellis Horwood. (In press)

Download references

Author information

Authors and Affiliations

  1. Institute of Pharmacology and Toxicology, University of Nifmegen, The Netherlands

    E. J. Ariëns

Authors
  1. E. J. Ariëns
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ariëns, E.J. Stereoselectivity, a natural aspect of molecular biology: A blind spot in clinical pharmacology and pharmacokinetics. Eur. J. Drug Metab. Pharmacokinet. 13, 307–308 (1988). https://doi.org/10.1007/BF03190095

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190095

Keywords

Search

Navigation